Krebs Biochemicals & Industries Limited (KREBSBIO)
Market Open
10 Aug, 10:00
XNSE XNSE Primary MSE ₹
57. 23
+2.19
+3.9789%
₹
1.84B Market Cap
- P/E Ratio
- Div Yield
6,232 Volume
- Eps
₹ 55.04
Previous Close Want to track KREBSBIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
KREBSBIO trading today higher at ₹57.23, an increase of 3.9789% from yesterday's close, completing a monthly decrease of -7.6489% or -₹4.74. Over the past 12 months, KREBSBIO stock lost -20.2925%.
KREBSBIO is not paying dividends to its shareholders.
The last earnings report, released on May 18, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Krebs Biochemicals & Industries Limited has completed 1 stock splits, with the recent split occurring on Jan 31, 2019.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).
KREBSBIO Chart
Krebs Biochemicals & Industries Limited (KREBSBIO) FAQ
What is the stock price today?
The current price is ₹57.23.
On which exchange is it traded?
Krebs Biochemicals & Industries Limited is listed on XNSE.
What is its stock symbol?
The ticker symbol is KREBSBIO.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 1.84B.
Has Krebs Biochemicals & Industries Limited ever had a stock split?
Krebs Biochemicals & Industries Limited had 1 splits and the recent split was on Jan 31, 2019.
Krebs Biochemicals & Industries Limited Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Jitendra Rameshchandra Shah CEO | XNSE Exchange | Y4987T116 CUSIP |
| India Country | 210 Employees | 14 Sep 2005 Last Dividend | 31 Jan 2019 Last Split | - IPO Date |
Overview
Krebs Biochemicals & Industries Limited is a prominent player in the pharmaceutical industry, focusing on the manufacture and sale of active pharmaceutical ingredients in India. With an emphasis on developing biotech processes, the company caters to diverse sectors including medicine, agriculture, and industry. Since its incorporation in 1991, Krebs Biochemicals has established a strong presence, with its headquarters located in Hyderabad, India. The company's dedication to innovation and quality has enabled it to serve as a reliable partner for large pharmaceutical and multinational companies, offering contract manufacturing services alongside its range of products.
Products and Services
- Androstenedione, Lovastatin, and Simvastatin: These products fall under the company’s offerings for anti-cholesterol and steroid intermediate applications. Androstenedione is a precursor in the biosynthesis of estrogens and testosterone, while Lovastatin and Simvastatin are widely used statins that help in lowering cholesterol levels in the blood, thus preventing heart diseases.
- Amlodipine, Cetirizine, Orlistat, Serratiopepetidase, Telmisartan, and Phenylephrine: This group of products showcases the company’s capacity to cater to a variety of therapeutic areas. Amlodipine is used for managing high blood pressure and angina; Cetirizine is an antihistamine for allergy relief; Orlistat is an anti-obesity medication; Serratiopepetidase is used for its anti-inflammatory properties; Telmisartan is another medication for high blood pressure; and Phenylephrine is a common decongestant for colds and coughs.
- Contract Manufacturing Services: Beyond its own product portfolio, Krebs Biochemicals extends its expertise to provide contract manufacturing services. This allows large pharmaceutical and multinational companies to outsource the production of drugs and ingredients, leveraging Krebs’ state-of-the-art facilities and extensive experience in the pharmaceutical manufacturing sector.
Contact Information
Address: Maas Heights
Phone: 91 40 6680 8040
Website: https://krebsbiochem.com
